Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Goodwill - Schedule of Goodwill (Details)

v3.24.0.1
Goodwill - Schedule of Goodwill (Details) - EUR (€)
€ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Goodwill € 49,983 € 47,243
Biopharmaceutical and Diagnostic Solutions    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Goodwill [1] 31,804 31,804
Engineering Systems    
Disclosure Of Reconciliation Of Changes In Goodwill [Line Items]    
Goodwill € 18,179 € 15,438
[1] For the purpose of the impairment test at December 31, 2022, the goodwill currently allocated to CGU Biopharmaceutical and Diagnostic Solutions amounting to EUR 31,804 thousand was allocated to the CGUs Drug Containment Solutions (DCS) and In-vitro Diagnostic Consumables & Drug Delivery Systems (IVD&DDS) for EUR 4,976 thousand and EUR 26,828 thousand respectively.